SHAREHOLDER ALERT: WeissLaw LLP Investigates Spring Bank Pharmaceuticals, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Spring Bank Pharmaceuticals, Inc. in connection with SBPH’s July 29, 2020 merger and exchange agreement with privately-held biopharmaceutical company, F-star Therapeutics Limited (“F-star”). Under the terms of the proposed transaction, SBPH will acquire the issued capital of F-star … Continue reading SHAREHOLDER ALERT: WeissLaw LLP Investigates Spring Bank Pharmaceuticals, Inc. Continue Reading


Each year, the IRS conducts hundreds of thousands of audits, looking into the accuracy of the returns of U.S. citizens from all walks of life and income levels across the country. The audit process rarely ends with the taxpayer being cleared and no changes are made to the return. Auditors ordinarily will find some mistakes or …
Vitality Biopharma, Inc., a drug development company dedicated to unlocking the unique therapeutic powers of cannabinoids, today announced that it has retained DelMorgan & Co., an internationally recognized investment banking firm, to advise Vitality on its strategic alternatives, including potential financings, asset divestitures or strategic partnerships. “We are thrilled to be working with DelMorgan to evaluate strategic …